CECR2


Description

The CECR2 gene, also known as the ‘chromatin licensing and DNA replication factor 2‘ gene, plays a crucial role in DNA replication and repair. It encodes a protein involved in the licensing of DNA replication origins, ensuring that each DNA strand is copied only once per cell cycle. This intricate process is essential for maintaining genomic stability and preventing the accumulation of mutations that can lead to cancer. Mutations in CECR2 can disrupt this precise regulation, increasing the risk of developing various cancers, including leukemia, lymphoma, and breast cancer.

Associated Diseases

Did you know?

Mutations in CECR2 are more prevalent in individuals with Fanconi anemia, a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.